Decreasing Incidence of Cancer After Liver Transplantation Decreasing Incidence of Cancer After Liver Transplantation
A decades-long study found a decrease in cancer risk after liver transplantation. What factors may have contributed to the decline?American Journal of Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 16, 2018 Category: Consumer Health News Tags: Transplantation Journal Article Source Type: news

Spontaneous Regression of a Squamous Cell Lung Cancer Spontaneous Regression of a Squamous Cell Lung Cancer
What might be the mechanism behind the spontaneous regression of this patient's stage I squamous cell lung carcinoma?Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 16, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

More choices for treating insomnia in cancer survivors: Acupuncture and cognitive behavioral therapy
(American Society of Clinical Oncology) ALEXANDRIA, Va. - A Patient-Centered Outcomes Research Institute (PCORI)-supported randomized clinical trial of cancer survivors showed that eight weeks of either acupuncture or cognitive behavioral therapy for insomnia (CBT-I) decreased the severity of insomnia among cancer survivors, though improvements were greatest among patients receiving cognitive behavioral therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news

Use of mobile and sensor technology lowers symptom severity for people with head and neck cancer
(American Society of Clinical Oncology) A federally funded, randomized clinical trial of 357 people receiving radiation for head and neck cancer, using mobile and sensor technology to remotely monitor patient symptoms, resulted in less severe symptoms related to both the cancer and its treatment (both general and cancer-related). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news

New regimens improve survival for children and young adults with T-cell cancers
(American Society of Clinical Oncology) In a federally funded, randomized phase III clinical trial performed by the Children's Oncology Group (COG), 90 percent of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84 percent were cancer free. These are the highest survival rates for these T-cell malignancies reported to date, according to the authors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news

Upfront, comprehensive genetic testing in advanced lung cancer is cost-effective
(American Society of Clinical Oncology) An economic model comparing different types of genetic testing in metastatic non-small-cell lung cancer (NSCLC) found that using next-generation sequencing (NGS) to test for all known lung cancer-related gene changes at the time of diagnosis was more cost-effective and faster than testing one or a limited number of genes at a time. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news

Made to measure sugar-like molecule could improve cancer-fighting antibodies
(Canadian Glycomics Network) Dr. Robert Britton firmly believes every molecule is important. This chemist doesn't want any molecule sitting unused on a laboratory shelf or in a fridge.'I want every molecule to have a purpose - that's my ethos for our lab,' says Britton, a GlycoNet network investigator and professor at Simon Fraser University. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news

Vast majority of heavy smokers not screened for lung cancer despite USPSTF recommendations
(American Society of Clinical Oncology) An analysis of 1,800 lung cancer screening sites nationwide found that only 1.9 percent of more than 7 million current and former heavy smokers were screened for lung cancer in 2016, despite United States Preventive Services Task Force (USPSTF) and ASCO screening recommendations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news

Shorter trastuzumab treatment for HER2+ breast cancer can be as effective, with fewer cardiac side-effects
(American Society of Clinical Oncology) A phase III randomized clinical trial of 4,088 women with HER2-positive, early-stage breast cancer found that taking trastuzumab (Herceptin) for 6 months was non-inferior to the current standard of 12 months. The disease-free survival rate at four years was 89.4 percent with 6 months of therapy and 89.8 percent with 12 months of therapy. In addition, only 4 percent of women in the 6-month arm stopped trastuzumab early because of cardiac problems, compared with 8 percent in the 12-month arm. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news

The Lancet Oncology: Patients' sex may impact efficacy of immunotherapy in cancer treatment
(The Lancet) A patient's sex might impact on the efficacy of immunotherapy in cancer treatment, according to a new meta-analysis of 20 randomised trials in over 11000 patients with advanced cancer published in The Lancet Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Blocking two enzymes could make cancer cells mortal
(Ecole Polytechnique F é d é rale de Lausanne) EPFL scientists have identified two enzymes that protect chromosomes from oxidative damage and shortening. Blocking them might be a new anticancer strategy for stopping telomerase, the enzyme that immortalizes tumors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news

Quartet of NFCR scientists publishes papers in immediate succession
(National Foundation for Cancer Research) Quartet of NFCR scientists publishes papers in immediate succession; the three articles offer possible bases for brain cancer treatments, insight into somatic mutations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news

Diagnosing breast cancer with an imaging pill
(American Chemical Society) For women, mammograms are a sometimes uncomfortable, but necessary, annual ritual. But this procedure doesn't always provide accurate results, and it exposes women to X-rays. In a study appearing in ACS' journal Molecular Pharmaceutics, scientists report that they have developed a non-invasive 'disease screening pill' that can make cancerous tumors light up when exposed to near-infrared light in mice without using radiation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Case Western Reserve, Lucid Diagnostics sign agreement on Barrett's Esophagus detector
(University Hospitals Cleveland Medical Center) Case Western Reserve University and Lucid Diagnostics, a subsidiary of publicly traded New York-based medical device company, PAVmed Inc. (Nasdaq: PAVM), have signed an exclusive license agreement to commercialize a technology that quickly and accurately detects Barrett's Esophagus. University Hospitals physicians will implement the technology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Bridge between epigenetics and cancer treatment
(Goethe University Frankfurt) Professor Stefan Knapp from the Institute of Pharmaceutical Chemistry and Buchmann Institute of Molecular Life Sciences at the Goethe University has been elected as one of 62 new members in the European scientific organization for molecular biology, EMBO, joining a group of more than 1800 of the best researchers in Europe and around the world. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Colon cancer -- Targeting tumor cell plasticity
(Ludwig-Maximilians-Universit ä t M ü nchen) Cell type switch helps colon cancer evade treatment, a study suggests. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

THE IADR/AADR publish JDR special issue on head and neck cancer
(International& American Associations for Dental Research) The International and American Associations for Dental Research (IADR/AADR) have published a special issue in the Journal of Dental Research (JDR) on head and neck cancer. Dr. Jacques E. N ö r, University of Michigan, Ann Arbor, USA, and Dr. J. Silvio Gutkind, University of California, San Diego, USA, served as the guest editors of this special issue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Colon cancer cells use mysterious RNA strands to avoid cell death
(Case Western Reserve University) Researchers from Case Western Reserve University School of Medicine have discovered how unusually long strands of RNA help colon cancer cells avoid death, allowing unregulated growth. Unlike other RNAs, the intriguing strands do not appear to encode proteins and are termed 'long non-coding RNAs' or 'lincRNAs.'A new study showed some lincRNAs could be targeted by drug developers to halt colon cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Reducing cholesterol could enhance T-cell cancer immunotherapy
(Cleveland Clinic) Cleveland Clinic researchers have demonstrated for the first time that lowering blood cholesterol levels could enhance the success of a specific type of T-cell immunotherapy in fighting cancer. The team, led by Qing Yi, M.D., Ph.D., of Cleveland Clinic Lerner Research Institute studied T-cell transfer, which has shown great success in recent years. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Cellular valve structure opens up potential novel therapies
(University of Zurich) Biochemists at the University of Zurich have determined the detailed structure of a volume-regulated chloride channel. This cellular valve is activated in response to swelling to prevent the cell from bursting. The protein also plays an important role in the uptake of chemotherapeutics and the release of neurotransmitters after a stroke. The controlled regulation of its activity thus opens up a promising strategy for novel therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

NIH, Northwestern scientists develop potential new approach to stop cancer metastasis
(NIH/National Center for Advancing Translational Sciences (NCATS)) Researchers have identified a compound that blocks the spread of pancreatic and other cancers in various animal models. When cancer spreads from one part of the body to another in a process called metastasis, it can eventually grow beyond the reach of effective therapies. Now, there is a new plan of attack against this deadly process, thanks to scientists at the National Institutes of Health, Northwestern University and their collaborative research partners. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

St. Jude named the WHO's first Collaborating Centre for Childhood Cancer
(St. Jude Children's Research Hospital) With the designation, St. Jude Children's Research Hospital will support efforts to improve detection and treatment of childhood cancer around the globe (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Damon Runyon Cancer Research Foundation announces five new Physician-Scientist Training Awards
(Damon Runyon Cancer Research Foundation) To help increase the number of physician-scientists, the Damon Runyon Cancer Research Foundation has created the new Damon Runyon Physician-Scientist Training Award, which provides physicians who have earned an MD degree and completed clinical specialty fellowship training the opportunity to gain the research experience they need to become leaders in translational and clinical research. Damon Runyon announced that five scientists with novel approaches to fighting cancer have been named the 2018 recipients of the award. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Mayo discovery means individualized ovarian, brain cancer therapies
(Mayo Clinic) Mayo Clinic researchers have discovered that a molecular communication pathway -- thought to be defective in cancer -- is a key player in determining the effectiveness of measles virus oncolytic cancer treatment in ovarian and aggressive brain cancers. This discovery enabled researchers to develop an algorithm to predict treatment effectiveness in individual patients. The findings appear in the Journal of the National Cancer Institute. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Under certain conditions, bacterial signals set the stage for leukemia
(University of Chicago Medical Center) A new study by researchers from the University of Chicago Medicine shows that bacterial signals are crucial to the development of a precursor condition to leukemia, which can be induced by disrupting the intestinal barrier or by introducing a bacterial infection. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

A 'dirty bomb' battles cancer metastasis
(Northwestern University) Scientists have developed a new compound that inhibits the spread of cancer cells, which is what makes the disease so lethal. The compound, metarrestin, significantly reduced metastasis by human prostate, pancreatic and breast cancer transplanted into mice. Mice treated with it had fewer metastatic tumors and lived longer than mice that did not receive treatment. Metarrestin is being submitted to the FDA as an investigational drug. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Cell type switch helps colon cancer evade treatment, study suggests
(Rockefeller University Press) Researchers in Germany have discovered that colon cancers are often resistant to existing drug treatments because they are composed of two different cell types that can replace each other when one cell type is killed. The study, which will be published May 16 in the Journal of Experimental Medicine, suggests that combination therapies targeting both cell types at once may be more effective at treating colorectal cancer, the third highest cause of cancer-related death in the United States. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Mayo study identifies new potential treatment option for triple negative breast cancer
In this study, Mayo investigators identified that the [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - May 16, 2018 Category: Research Source Type: news

Mayo discovery means individualized ovarian, brain cancer therapies
ROCHESTER, Minn. ??Mayo Clinic researchers have discovered that a molecular communication pathway ? thought to be defective in cancer ? is a key player in determining the effectiveness of measles virus oncolytic cancer treatment in ovarian and aggressive brain cancers. This discovery enabled researchers to develop an algorithm to predict treatment effectiveness in individual patients. [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - May 16, 2018 Category: Research Source Type: news

Queens Medical Associates to Hold Inaugural Clinical Trials Day on May...
Leading oncology and hematology practice educates public on importance of clinical trials, patient opportunities and advances in cancer treatment(PRWeb May 16, 2018)Read the full story at https://www.prweb.com/releases/2018/05/prweb15492065.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 16, 2018 Category: Pharmaceuticals Source Type: news

Queens Medical Associates to Hold Inaugural Clinical Trials Day on May...
Leading oncology and hematology practice educates public on importance of clinical trials, patient opportunities and advances in cancer treatment(PRWeb May 16, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15492065.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 16, 2018 Category: Pharmaceuticals Source Type: news

Colon Polyp Type May Be Key to Cancer Risk
(Source: Cancercompass News: Colorectal Cancer)
Source: Cancercompass News: Colorectal Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Stunned scientists find BLUEBERRIES are better at destroying cancer cells than conventional radiation therapy alone
(Natural News) Cervical cancer strikes close to 13,000 women each year, claiming over 4,200 lives. Traditional treatment options include surgery to remove the affected tissue, radiation therapy using high energy x-rays to destroy cancer cells, chemotherapy drugs to destroy the affected cells (although healthy cells are killed too), or a combination thereof. However, these treatments... (Source: NaturalNews.com)
Source: NaturalNews.com - May 15, 2018 Category: Consumer Health News Source Type: news

Open records request reveals shocking e-mail from Kraft scientist claiming the "IARC is killing us!"
(Natural News) If the top cancer research agency in the world links one of your products to cancer, what should you do? The responsible thing would be to pull the product from the market and try to get to the bottom of the situation. If you feel they’re wrong, the most obvious course of action... (Source: NaturalNews.com)
Source: NaturalNews.com - May 15, 2018 Category: Consumer Health News Source Type: news

Iowa Man's Glyphosate Cancer Case Against Monsanto Sent To Roundup MDL
WASHINGTON, D.C. - The Judicial Panel on Multidistrict Litigation (JPMDL) on May 10 transferred to the multidistrict litigation for Roundup products liability litigation a case in which an Iowa man contends that he developed T-cell lymphoma as a result of exposure to glyphosate and other chemicals in the herbicide Roundup (In re: Roundup Products Liability Litigation, MDL No. 2741, N.D. Calif.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - May 15, 2018 Category: Medical Law Source Type: news

Texas Panel Reverses $6.98M Benzene Ruling, Says Causation 'Legally Insufficient'
DALLAS - A Texas appellate panel on May 8 reversed a trial court judgment of $6,985,535.25 and rendered a take-nothing judgment in favor of E.I. DuPont de Nemours and Co. after the panel determined that the evidence of causation regarding the company's liability for a man's cancer diagnosis related to benzene exposure was "legally insufficient" (E.I. DuPont de Nemours& Company v. Virgil Hood, et al., No. 05-16-00609-CV, Texas. App., 5th Dist.; 2018 Tex. App. LEXIS 3228). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - May 15, 2018 Category: Medical Law Source Type: news

Residents Sue Remediation Company For Falsifying Soil Samples From Superfund Site
SAN FRANCISCO - One hundred forty-nine residents who live near a Superfund site in San Francisco sued an environmental remediation company in California state court May 1, claiming that the company falsified soil samples during its alleged cleanup of the property and that its failure to fully complete the work it was paid $1.1 billion to do has led to higher rates of breast and cervical cancer and asthma (Bayview Hunters Point Residents, et al. v. Tetra Tech Inc., et al., No. CGC-18-566188, Calif. Super., San Francisco Co.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - May 15, 2018 Category: Medical Law Source Type: news

More men with low-risk prostate cancer are forgoing aggressive treatment
American doctors are successfully persuading increasing numbers of men with low-risk prostate cancer to reject immediate surgery and radiation in favor of surveillance, a trend that is sparing men's sexual health without increasing their risk of death. The latest evidence that more men are postponing aggressive therapy unless their symptoms worsen came in a large […]Related:Ebola has infected dozens so far in Congo, killing 19, WHO saysTroubling link found between pollution exposure in pregnancy, high blood pressure in childrenFor six decades, ‘the man with the golden arm’ donated blood — and saved...
Source: Washington Post: To Your Health - May 15, 2018 Category: Consumer Health News Source Type: news

Colon Polyp Type May Be Key to Cancer Risk
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 15, 2018 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Preventive Medicine, News, Source Type: news

MRI-Targeted Biopsy Prevails in Prostate Cancer
(MedPage Today) -- More significant, fewer insignificant cancers versus TRUS (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 15, 2018 Category: Hematology Source Type: news

Only Advanced Adenomas Confer Colorectal Cancer Risk
(MedPage Today) -- Risk with non-advanced lesions no greater than with no lesions at all (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - May 15, 2018 Category: Gastroenterology Source Type: news

Baby bibs, blankets contain toxins Canada banned in other products: report
Baby bibs, mats and blankets tested by scientists with NAFTA's environmental arm contain toxic chemicals linked to higher rates of cancer, infertility and suppressed immune systems — substances already banned from most other products in Canada. (Source: CBC | Health)
Source: CBC | Health - May 15, 2018 Category: Consumer Health News Tags: News/Politics Source Type: news

More men with low-risk prostate cancer are forgoing aggressive treatment, new study suggests
American doctors are successfully persuading increasing numbers of men with low-risk prostate cancer to reject immediate surgery and radiation in favor of surveillance, a trend that is sparing men's sexual health without increasing their risk of death. The latest evidence of the long-term trend came in a large study published Tuesday that involved more than […]Related:Ebola has infected dozens so far in Congo, killing 19, WHO saysTroubling link found between pollution exposure in pregnancy, high blood pressure in childrenFor six decades, ‘the man with the golden arm’ donated blood — and saved 2.4 m...
Source: Washington Post: To Your Health - May 15, 2018 Category: Consumer Health News Source Type: news

Bursectomy Does Not Improve Survival in Resectable Gastric Cancer Bursectomy Does Not Improve Survival in Resectable Gastric Cancer
In patients with resectable gastric cancer, bursectomy does not offer a survival advantage over the less radical omentectomy, researchers from Japan report.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - May 15, 2018 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Survival With Cervical Cancer Similar After Trachelectomy, Hysterectomy Survival With Cervical Cancer Similar After Trachelectomy, Hysterectomy
Trachelectomy to preserve fertility is being performed in a growing number of cervical cancer patients, especially those younger than 30, according to new findings.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - May 15, 2018 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Takeda Sees Lower Annual Profit, Generics to Erode Cancer Drug Sales Takeda Sees Lower Annual Profit, Generics to Erode Cancer Drug Sales
Japan's Takeda Pharmaceutical Co Ltd on Monday forecast a 17 percent drop in operating profit for the year through March 2019 as blood cancer drug Velcade (bortezomib) looks set to face generic competition in the United States.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 15, 2018 Category: Consumer Health News Tags: Pharmacist News Source Type: news

Improving Adherence to Endocrine Therapy in Women With HR-Positive Breast Cancer
Here, we discuss how to improve adherence to endocrine therapy in women with HR-positive breast cancer, as well as the side effects and the reasons for discontinuation. (Source: CancerNetwork)
Source: CancerNetwork - May 15, 2018 Category: Cancer & Oncology Authors: Charles L. Shapiro, MD Julia P. Brockway, MD Tags: Breast Cancer Oncology Journal Source Type: news

Initiation of ADT in a Man With Locally Advanced Prostate Cancer and Multiple Cardiovascular Risk Factors
A 65-year-old man presented with locally advanced, high-risk prostate cancer. His medical history was remarkable for type 2 diabetes mellitus, and he was an active smoker with a 27 pack-year history. (Source: CancerNetwork)
Source: CancerNetwork - May 15, 2018 Category: Cancer & Oncology Authors: Francisco J. Castro-Alonso, MD Guillermo Rosales-Sotomayor Jennifer Dominguez-Pineda, MD Mar ía T. Bourlon, MD, MS Thomas W. Flaig, MD Tags: Genitourinary Cancers Oncology Journal Prostate Cancer Source Type: news

Robert Chapkin on Relationships Between the Gut Microbiome, Diet, and Colorectal Cancer
In this Q&A, we discuss the research into the relationships between gut microbiota, diet, and colorectal cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 15, 2018 Category: Cancer & Oncology Authors: Robert S. Chapkin, MSc, PhD Tags: Colorectal Cancer Gastrointestinal Cancer Oncology Journal Source Type: news

More men with low-risk prostate cancer are rejecting aggressive treatment, new study suggests
A sea change is occurring among men with low-risk prostate cancer: Increasing numbers are avoiding immediate surgery or radiation and are opting instead for close monitoring of the disease to see whether it worsens. The shift is sharply reducing unnecessary treatment that can cause serious side effects including incontinence and sexual problems, experts say, without […]Related:Ebola has infected dozens so far in Congo, killing 19, WHO saysTroubling link found between pollution exposure in pregnancy, high blood pressure in childrenFor six decades, ‘the man with the golden arm’ donated blood — and sa...
Source: Washington Post: To Your Health - May 15, 2018 Category: Consumer Health News Source Type: news